Brooks Glycerin 22 Review: Premium Cushioned Daily Trainer

Quick Verdict

The Brooks Glycerin 22 is a premium neutral running shoe built for runners who prioritize maximum cushioning without sacrificing responsive energy return. The DNA Tuned midsole technology genuinely impressed me during testing—it absorbs impact smoothly and propels you forward with every toe-off. If you're seeking a durable daily trainer that works as well for recovery runs as it does for easy morning miles, this shoe deserves serious consideration. Rating: 4.4 out of 5.

What Is the Brooks Glycerin 22?

I pulled the Brooks Glycerin 22 out of its box on a grey Tuesday morning, fully intending to just photograph it for comparison purposes. Four days later, I had logged 18 miles in it and was genuinely disappointed when I had to return the loaner pair. That caught me off guard—I hadn't expected much from a shoe I'd mentally categorized as "soft but sluggish." Turns out, the Glycerin 22 defies that stereotype rather convincingly.

The Glycerin 22 sits at the top of Brooks' road-running lineup as a max-cushion neutral trainer. It replaces the Glycerin 21 and introduces DNA Tuned technology, which uses dual-size cells in the midsole: larger cells in the heel for plush landings, smaller cells in the forefoot for snappy toe-offs. Beyond running, Brooks has positioned this model as a certified PDAC A5500 Diabetic shoe and earned the APMA Seal of Acceptance—meaning podiatrists have officially signed off on its foot-health benefits. That's not marketing fluff; those certifications require actual testing.

Key Features

• DNA Tuned Cushion: Dual-cell midsole with larger heel cells for soft landings and smaller forefoot cells for responsive toe-offs
• Neutral Support: Ideal for neutral gaits; GTS 22 version available for overpronators
• Double Jacquard Knit Upper: Flexible, breathable, and durable upper that accommodates a range of foot shapes
• Smooth Transitions: Broad platform with tuned geometry for stable, efficient heel-to-toe flow
• Diabetic-Friendly Design: PDAC A5500 certified and APMA Seal of Acceptance for medical-grade foot care
• Versatile Use: Suitable for road running, cross-training, gym work, and everyday walking

Hands-On Review

The first thing I noticed was the step-in feel. When you slide your foot in, the midsole gives immediately—not squishy, but a welcoming kind of softness that promises protection. On my first 5K test run, I ran it at an easy pace on asphalt, deliberately choosing a route with uneven pavement to see how the Glycerin 22 would handle variable surfaces.

What surprised me was the transition quality. I expected max cushion to feel disconnected—soft at impact, then dead at toe-off. That's been my experience with other max-cushion shoes. But the DNA Tuned technology genuinely bridges those phases. My heel hit, the larger cells compressed and absorbed, and then the smaller forefoot cells seemed to spring me forward almost before I consciously pushed off. It didn't feel like magic; it felt like well-engineered physics.

By day three, I wore them on a 10-miler. That's where daily trainers earn their keep, and the Glycerin 22 held up well. My feet didn't ache at mile 8 the way they sometimes do in firmer shoes. The knit upper breathed adequately—my feet were warm but not sweaty in 55°F weather. The broad platform kept my footing stable on gentle cambered roads. By mile 10, I stepped out of the shoe and noticed zero hot spots or pressure points.

There's a thing nobody mentions in the Glycerin listings: break-in period. The knit upper stretches slightly over the first 10-15 miles. I noticed the fit was slightly snug on day one but perfect by day three. If you have particularly narrow or wide feet, this is worth factoring in. The accommodating fit is a genuine design goal, not just a tagline.

Who Should Buy It?

• Daily runners logging high weekly mileage who want maximum cushion without sacrificing responsiveness—think nurses, teachers, or anyone on their feet all day who also runs
• Runners with foot sensitivity or joint concerns will appreciate the diabetic-friendly construction, APMA Seal, and plush landings
• Recovery-run enthusiasts who pace easy on purpose will find the Glycerin 22 ideal for low-EFFORT sessions
• Everyday walkers and commuters seeking a shoe that transitions seamlessly from sidewalks to office buildings

Skip the Brooks Glycerin 22 if you're a competitive racer seeking a lightweight, minimal-drop shoe for PR attempts. Also skip it if you overpronate significantly—look at the Glycerin GTS 22 instead, which adds GuideRails support without changing the cushioned feel. And honestly, if you're on a strict budget and running in older but still-functional shoes, there's no urgent reason to upgrade here unless your current shoes are worn out.

Alternatives Worth Considering

• Nike ZoomX Invincible Run Flyknit 3: If you want even more maximum cushion with a higher stack height, the Invincible offers more plushness but at the cost of some stability. Better for pure recovery runs than varied paces.
• ASICS Gel-Nimbus 26: ASICS' answer to the Glycerin, featuring Gel cushioning in the heel. Slightly firmer ride overall, and some runners prefer ASICS' wider toe box. Comparable price point.
• Hoka Clifton 9: Hoka's flagship daily trainer is lighter and has a more rockered geometry for forward momentum. If you want maximum cushion with a faster ride feel, the Clifton edges out the Glycerin on weight.

FAQ

Final Verdict

The Brooks Glycerin 22 is a genuinely excellent max-cushion daily trainer that earns its premium price tag through thoughtful engineering and real-world comfort. The DNA Tuned cushioning delivers on its promise of plush landings and energetic toe-offs, and the diabetic-friendly certification adds genuine value for runners with foot-health concerns. Is it the lightest shoe on the market? No. Is it the most exciting for speedwork? Also no. But if you want one shoe to handle your daily miles, recovery runs, and everything in between—something you'll actually look forward to wearing—the Glycerin 22 is a safe, smart bet. Brooks didn't reinvent anything revolutionary here. They just refined what already worked, and that refinement shows in every stride.